Perceptive Advisors LLC Incyte Corp Call Options Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $91.9 Million - $127 Million	-1,510,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $125 Million - $152 Million	1,510,000 New	1,510,000 $6.95 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $9.36 Million - $11.7 Million	-100,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $10.9 Million - $13.8 Million	100,000	100,000 $35,000

641

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.